The allotypic determinants exclusively expressed on suppressor T cells (Tsud) a or inducer of suppressor T cells (Tind d) have been demonstrated (1, 2) by antisera or monoclonal antibodies that were made by immunizations of an immunoglobulin heavy chain (Igh) allotype congenic pair of mice (i.e., BALB/c anti-C. . The genes coding for the T cell allotypic determinants have unambiguously been mapped between the Igh constant region genes (Igh-C) and the prealbumin gene (Pre-1) on the 12th chromosome (3). Furthermore, the determinants seem to be present on the antigen receptor on suppressor T cells because the binding of idiotype-specific suppressor T cells to the idiotype-bearing Ig was blocked by the antiserum (1). Therefore, these results suggested that T cell antigen receptors can be encoded by genes linked to the Igh genes.
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The allotypic determinants exclusively expressed on suppressor T cells (Tsud) a or inducer of suppressor T cells (Tind d) have been demonstrated (1, 2) by antisera or monoclonal antibodies that were made by immunizations of an immunoglobulin heavy chain (Igh) allotype congenic pair of mice (i.e., BALB/c anti-C.AL-20). The genes coding for the T cell allotypic determinants have unambiguously been mapped between the Igh constant region genes (Igh-C) and the prealbumin gene (Pre-1) on the 12th chromosome (3) . Furthermore, the determinants seem to be present on the antigen receptor on suppressor T cells because the binding of idiotype-specific suppressor T cells to the idiotype-bearing Ig was blocked by the antiserum (1) . Therefore, these results suggested that T cell antigen receptors can be encoded by genes linked to the Igh genes.
In fact, we have been able to demonstrate (4) that the antiserum made by immunizations of BALB/c (H-2 a, Igh-1 o) mice with T cell blasts from the Igh allotype cogenic mice CB-20 (H-2 a, Igh-1 b) detects the allotypic determinants on the antigenspecific T cell factors, i.e., suppressor (TsF) or augmenting factor (TaF), which suppresses or augments the in vitro secondary IgG antibody response. Further evidence (4, 5) has suggested that the anti-CB-20 antiserum contains at least two distinct antibodies recognizing the constant region determinants on the antigen-binding molecules (Ct) of the functionally different T cell factors (i.e., TsF or TaF). Genetic analysis (5) of the determinants using the antiserum also indicated that the allotypic determinants on the T cell factors are encoded by genes linked to the Igh-1 b genes. These genes are distinctly located on the right side of the Igh variable-region (Igh-V) genes on the 12th chromosome because the anti-CB-20 column specifically reacted with T cell factors from BAB-14 mice that carry the Igh-V genes from Igh-1 a mice and the Igh-C genes from Igh-1 b mice.
Based on the above evidence, we tried to establish hybridoma-producing monoclonal antibodies recognizing the Ct determinants of the antigen-specific T cell factors (T cell-receptor molecules) expressed on the functionally distinct T cell subsets. Such monoclonal antibodies would be useful for characterizing the biochemical properties of the antigen-recognition units on T cell subsets. In this report, we describe the establishment of three characteristic monoclonal anti-CB-20 antibodies, each of which reacts with the distinct constant-region determinants on the antigen-binding chain of TsF or TaF. By using these monoclonal antibodies, some functional and genetic properties of the T cell factors will also be described. Immunization. Immunization protocol to produce antibodies specific for T cell factors was described previously (4) . Briefly, BALB/c mice were immunized intravenously with 107 CB-20 spleen cells preeultivated with 5 #g/ml of concanavalin A (Con A; Sigma Chemical Co.) for 48 h. The animals were immunized more than 10 times at weekly intervals.
Materials and Methods

Animals
Cell Fusion and Cloning. 3 d after the last immunization, cell hybridization was carried out by the method described elsewhere (6) . In brief, l0 s primed spleen cells were mixed with 10 7 P3-X63Ag8-U 1 (P3U1) in a 50-ml tube and pelleted by centrifugation at 400 g. The cells were then resuspended in 1 ml prewarmed (37°C) 50% polyethylene glycol (PEG; 1,500 mol wt; Sigma Chemical Co.) by gentle shaking, followed by the dropwise addition of 1 ml of serumfree RPMI 1640 (GIBCO Laboratories, Grand Island Biochemical Co., Grand Island, NY). The cells were further diluted with RPMI 1640 and then centrifuged at 200 g for 5 min. The cell pellet was resuspended with warm medium containing 1 × 10-M hypoxanthine, 4 × 10 -7 M aminopterin, and 1.6 × 10 -5 M thymidine (HAT). 100 /L1 of the cell suspensions was distributed to each well of a 96-well tissue culture plate (3042; Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, CA). Hybrids were cultured in HAT medium for 2-4 wk. Culture supernatants were added to the spleen cell culture to detect the antibody activity, as described below. Cells in the positive wells were cloned at least twice with limiting dilution.
Cytotoxic Test. The two-step cytotoxic assay was performed as described elsewhere (6) . 105 containing TsF and TaF was applied to immunoadsorbent columns composed of monoclonal antibodies and incubated for 1 h at 4°C. Effluent was collected by passing through the columns. After extensive washing with RPMI 1640 medium, the materials were then eluted from the columns with 2 ml of 0.175 M glycine-HC1 buffer, pH 3.2, at 4°C. The eluates were instantly neutralized with 0.4 M sodium bicarbonate and dialyzed with phosphate-buffered saline (PBS), pH 7.2. They were then concentrated by vacuum pressure.
In Vitro Culture System. Modified Mishell-Dutton culture system using a 96-well microtiter plate (Falcon 3042) was used. 8 5 .... × 10 spleen cells from mine primed 6 wk previously wxth 100 ~g of DNP-KLH or DNP-OVA and 10~BPV were cultured in 0.2 ml of RPMI 1640 enriched with 10% fetal calf serum in the presence of 0.1 #g/ml of DNP-KLH or DNP-OVA and 2 × 10 -5 M 2-mercaptoethanol at 37°C in 5% CO2 in air for 5 d. 10 btl of cell-free extract equivalent to 2 X 106 spleen cells was added to the culture on day 0, to examine the TsF activity, or on day 2, for testing the TaF activity. 5 d later, numbers of anti-DNP IgG plaque-forming cells (PFC) were assayed by using DNP-coupled erythrocytes.
Statistical Analysis. For in vitro PFC assays, results were analyzed with a two-tailed Student's t test. Probability values of > 10% were considered to be insignificant.
Results
Screening of the Monoclonal Anti-CB-20 Antibodies Specific for Functional T Cell
Factors. Our previous studies (4) have shown that immunizations of BALB/c mice with Igh allotype-congenic spleen cells (CB-20) successfully produced antisera specific for the allotypic determinants of T cell factors (TsF or TaF). Therefore, BALB/ederived myeloma cells (P3U1) were hybridized with spleen cells of BALB/c mice hyperimmunized with CB-20 spleen cells. To select hybridoma-producing antibodies specific for TsF or TaF, DNP-KLH-primed spleen cells were cultivated with hybridoma culture supernatant in the presence or absence of the KLH-specific T cell factors. As shown in Table I , culture supernatants of the 7C5, 7D1, or 6A4 clone did not show DNP-KLH-primed spleen cells from C57BL/6 mice were cultured in 0.2 ml of a 96-well microtiter plate in the presence of hybridoma supernatants and antigen-specific T cell factors. :~ 50/~1 of hybridoma supernatant or medium was added to the in vitro secondary anti-DNP IgG response of spleen cells of C57BL/6 mice at the start of cultivation. § The cell-free extract equivalent to 2 × 106 spleen cells of KLH-primed C57BL/6 mice was added to the culture on day 0 to detect the TsF activity. II The cell-free extract equivalent to 2 × 106 spleen cells of KLH-primed C57BL/6 mice was added to the culture on day 2 to detect the TaF activity. ¶ Significance level of difference from the spleen cell culture without TaF (control). ** Results are expressed as arithmetic mean numbers of anti-DNP IgG PFC of six cultures + SD. ~:~ Not done. § § Not significant. any effect on the in vitro secondary antibody response when they were cultured with spleen cells in the absence of the T cell factors. However, the hybridoma supernatants abrogated the KLH-TsF or KLH-TaF activity in the presence of T cell factors. These results suggest that the hybridoma antibodies specifically reacted with TsF or TaF and resulted in eliminating the activities of the T cell factors. The isotype of the 7C5, 7D1, or 6A4 antibody was found to be IgM, IgM, IgG1, respectively, as determined by radioimmunoassay described elsewhere (8) .
Monoclonal Anti-CB-20 (7C5, 6A4, and 7D1) Antibodies Recognizing Constant Region
Determinants on Antigen-specific T Cell Factors. To examine the determinants of T cell factors recognized by monoclonal anti-CB-20 antibodies, the KLH-or OVA-specific T cell factors were absorbed with immunoadsorbent columns of the 7C5, 6A4, or 7D 1 antibody. The materials were also eluted from the columns with 0.175 M glycine-HC1 buffer, pH 3.2. The effluent or the eluate was added to the culture of DNP-KLH-or DNP-OVA-primed spleen cells on day 0, to detect the suppressor (TsF) activity, and also added on day 2, to determine the augmenting (TaF) activity. The data shown in Table II demonstrated that the 7C5 column absorbed the KLH-TsF and OVA-TsF but not TaF. On the contrary, the 6A4 reacted only with TaF. These results indicate that the 7C5 and 6A4 antibodies recognize the distinct constant region determinants exclusively expressed on the TsF and TaF, respectively. The 7D1 antibody was, however, shown to be directed to the constant region determinants shared in TsF and TaF because the 7D1 column absorbed both TsF and TaF. The genetic specificity of the 7C5 antibody (IgM) specific for TsF was also investigated by a cytotoxic inhibition assay. The diluted culture supernatant of the 7C5 clone that showed an end point of maximum cytotoxic activity was absorbed with graded numbers of spleen cells from various strains of mice. The residual cytotoxic activity was tested on the suppressor T cell hybridoma. * The cell-free extract equivalent to 2 × 106 spleen cells of KLH-or OVA-primed C57BL/6 mice was absorbed with and eluted from immunoadsorbent columns of monoclonal antibodies. :~ The effluent or the eluate from the columns was added to the culture on day 0 (TsF) or on day 2 (TaF) to detect the TsF or TaF activity. § The KLH-specific or OVA-specific spleen cell extract from C57BL/6 mice was added on day 0 to the culture of DNP-KLH-(upper column) or DNP-OVA-(lower column) primed spleen ceils from C57BL/6 mice, respectively. 11 The KLH-specific or OVA-specific spleen cell extract from C57BL/6 mice was added on day 2 to the culture of DNP-KLH-(upper column) or DNP-OVA-(lower column) primed spleen ceils from C57BL/6 mice, respectively. ¶ Significance level of difference from the spleen cell culture without TaF (control). ** Results are expressed as arithmetic mean numbers of anti-DNP IgG PFC of six cultures + SD. :~k Not significant.
Genetic Specificity of Monoclonal Anti-CB-20 (7C5, 6A4,and 7DI) Antibodies.
7C5 antibody recognizes T cell surface products encoded by Igh-lb-linked genes.
Allotypic Determinants Are Present on Antigen-binding Chains of T Cell Factors. It has
been demonstrated (10, 11) that KLH-TsF is composed of two discrete molecules, i.e., the KLH-binding and the I-J-bearing chains in noncovalent association in the extracted TsF, and that these two chains, neither of which could exert any function by itself, reconstituted the TsF activity when mixed together. Therefore, the extracted KLH-TsF was absorbed with immunoadsorbent columns composed of KLH, 7C5, or anti-I-J b to determine whether the 7C5 reacts with the KLH-binding or the I-Jencoded molecule. The effluents, or a mixture of these from any two of the columns, were added to the culture on day 0. The results shown in Table IV demonstrated that the TsF activity was completely absorbed with any of the columns. No suppressor activity was detected in the effluent from the columns. However, the mixture of the effluents from the KLH and anti-I-J b or from the 7C5 and anti-I-J b, but not those from the KLH and 7C5 columns, reconstituted the strong suppressor activities. From our previous experiments, together with the results shown in Table IV , the effluent ¶ Significance level of difference from the spleen cell cuture without TaF; P < 0.001. ** Significance level of difference from the spleen cell culture without TaF; P > 0.1 (NS). from the anti-I-j b column should contain the KLH-binding molecule. Similarly, the KLH column supplies the I-J molecules in the effluent. Because the 7C5 column behaves the same as the KLH column in Table IV , it is likely that 7C5 has the capacity to absorb the KLH-binding molecules but not the I-J molecules. * The cell-free extract equivalent to 8 X 108 spleen cells from KLH-primed C57BL/6 mice was adsorbed with immunoadsorbent columns. :~ The effluent or the mixture of the one-half volume of effluents from these columns was added to the DNP-KLH-primed C57BL/6 spleen cell culture on day 0 or on day 2. § Significance level of difference from the spleen cell culture without TaF (control).
As TaF has been demonstrated to have the antigen-binding moiety and the I-A-
[I Results are expressed as mean numbers of anti-DNP IgG PFC of six cultures ± SD. ¶ Cell numbers equivalent to the amount of absorbed factors added to the culture. ** Not significant. :H: Not done. subregion gene products, the experiment was designed to examine whether TaF is composed of two chains like TsF and whether the determinant defined by 6A4 is present on the antigen-binding molecule. For this, a similar experiment described in the previous section using the anti-I-A b and 6A4 columns was carried out. In this experiment, the extracted T cell factor was added to the culture on day 2. The results in Table IV show that the augmenting activity was reconstituted by the mixture of the effluents from the KLH and anti-LA b or from the 6A4 and anti-I-A b columns, neither of which showed any TaF activity by itself. The results indicate that TaF is also composed of two chains and that the 6A4 antibody reacted the molecules with antigen-binding moiety of TaF. It is, therefore, concluded that 7C5 and 6A4 recognize the determinants expressed on the antigen-binding molecules of the functional subsets of T cells.
Discussion
The hybridomas producing antibodies specific for allotypic markers on the antigenbinding molecules of functional T cell factors have been established by the fusion of BALB/c myeloma (P3U1) and BALB/c spleen cells hyperimmunized with Con Astimulated spleen cells of Igh allotype congenic mice (CB-20). The antibodies were successfully selected by functional assays as shown in Table I . The 7C5 and 7D1 antibodies (IgM) were seen to have the ability to block the TsF activity when they were added together with TsF into the in vitro secondary antibody responses. Similarly, the addition of the 6A4 antibody (IgG1) to the culture resulted in abrogating the TaF activity.
The reactivity of monoclonal antibodies was further investigated. It is demonstrated in Table III that The antigen-specific suppressor T cell factor has been demonstrated to bear the antigen-binding structure as well as the constant region determinants that were defined by the xenoantiserum against mouse suppressor T cell factors (rabbit antimouse TsF) (12) . No genetic analysis of constant determinants on TsF was performed. However, recent studies reported by Owen et al. (1) and Tokuhisa and Taniguchi (4) have strongly suggested that T cell allotypic determinants encoded by genes linked to the Igh locus are expressed on T cell antigen receptors or antigen-specific T cell factors. In this respect, the monoclonal antibodies (7C5, 7D1, and 6A4) were found to recognize constant region determinants on antigen-binding molecules of T cell factors (Tables II and IV) because the monoclonal antibody has the ability to absorb both KLH-and OVA-specific T cell factors, both of which should have the distinct variable region structure. However, our results in Tables II and IV could not exclude the possibility that the antibody might react with variable region determinants in case there might be allotypic markers in the variable region of the T cell receptor similar to the allotypes of the rabbit Ig (13) .
It is clear that the monoclonal 6A4 and 7C5 antibodies recognize the distinct antigen-binding molecule on different functional T cell factors (Tables II and IV) . However, the 7D1 antibody recognizes the shared constant determinants between TsF and TaF (Table II) . Therefore, at least two discrete genes coding for the Ct of T cell receptors can be supposed to be present on the 12th chromosome. Genetic specificities of the monoclonal antibodies have further shown that both genes coding for the Ct molecules locate to the right side of the Igh-V genes on the 12th chromosome because the antibodies absorb T cell factors from Igh-1 b mice and BAB-14 mice carrying the Igh-C genes from Igh-1 b mice and the Igh-V genes from Igh-1 '~ mice (14) . In this respect, the existence of a gene complex, downstream from Igh-1 and coding for a family of T cell isotypes (Tsu d, Tind d, or Tthyd), has been proposed by Owen et al. (15) . We cannot determine at this time whether or not the Ct determinants defined by our monoclonal reagents are identical to Tsu d and Tind d. In any event, it is possible that the cluster of genes coding for the constant region determinants of antigen-receptors on functionally different T cell subsets locates adjacent to the Igh-C genes on the 12th chromosome.
We previously reported the existence of the antigen-specific T cell factor (TaF) that augments antibody responses (7) . "This factor was shown to possess an I region determinant encoded by an unique gene in the I-A subregion that is not identical to that coding for the B cell Ia antigen (7, 16) . The results in Table IV demonstrate that TaF is composed of two distinct chains, one possessing the antigen-binding moiety and the other the product of a gene in the I-A subregion and that the 6A4 antibody reacts with the molecules having the KLH-binding moiety. Therefore, the antigenspecific TaF has a structural resemblance to the antigen-specific TsF (10) . TaF was also found to have similar characteristics to TsF in that the mixture of the two chains, neither of which could exert any functional activity by itself, could successfully reconstitute the augmenting activity.
From our previous studies on the hybridoma-derived TsF (10, 11) , together with the data presented here, it is strongly suggested that I region gene products being associated with the antigen-binding chain of T cell factors act as elements to convey T cell functions (i.e., suppressing or augmenting). As antigen-binding chains have the Ct determinants unique to functionally different T cell subsets, it is also likely that the Ct molecules serve as functional domains of T cell factors similarly to the Fc domain of Ig. In this regard, it is imperative to conduct investigations of the biological roles of the molecules responsible for the expression of the functions of the T cell factors. Further studies using monoclonal antibodies (7C5 and 6A4), currently in progress, are awaiting results to answer these questions. (Igh-I b) mice. The 7C5 or 6A4 antibody reacts with the constant region determinants on the antigen-binding molecule (Ct) of the antigen-specific suppressor T cell factor (TsF) or augmenting T cell factor (TaF), respectively. The 7D1 antibody, however, recognizes the shared determinants on the Ct molecules of TsF and TaF. Genetic studies of determinants recognized by these monoclonal antibodies have also suggested that the distinct Ct molecules of TsF and TaF are encoded by two discrete genes linked to the Igh-1 b genes, which are located on the right side of the variable genes of Igh on the 12th chromosome. By using the immunoadsorbent columns of 6A4 antibody and anti-I-A b, TaF, in a manner similar to TsF, was demonstrated to be composed of two chains, i.e., the Ct molecules and the I-A-encoded products. Furthermore, the Ct-bearing molecules were shown to possess the antigen-binding moiety.
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